The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

Performance was driven by a deliberate strategic shift toward higher-value, high Average Selling Price (ASP) production systems, which improved revenue quality and operating leverage.

The medical sector emerged as a primary growth engine, increasing 54% year-over-year due to strong demand for balloon catheter coating and advanced medical technologies.

Clean energy demand declined 19% as policy shifts at the government level impacted electrolysis-related orders, though this was partially offset by earlier solar system shipments.

Gross margins expanded to 51% because customers are increasingly paying for Sono-Tek’s process expertise and integrated 'turnkey' solutions rather than just hardware.

Geographic concentration in the U.S. (67% of revenue) benefited both top-line growth and margins by reducing international logistics and compliance costs.

Operating income grew 81% year-over-year, demonstrating the business's ability to scale profitability even with modest 2% revenue growth through favorable product mix.

Management successfully repurposed machine integration capabilities originally developed for clean energy to capture emerging opportunities in the microelectronics and medical markets.

Management expects continued revenue growth and profitability in the first half of fiscal 2027, supported by momentum in medical and microelectronics sectors.

Full-year fiscal 2027 revenue is projected to be relatively flat to modestly higher, with limited visibility in the second half due to clean energy policy uncertainty.

The transition to larger, more complex system orders has resulted in longer lead times and less predictable shipment timing, creating potential quarterly revenue volatility.

A new 300-millimeter wafer coating machine for the semiconductor fab market is scheduled for introduction in late calendar 2026, with revenue contributions expected in fiscal 2028.

The company is planning a phased manufacturing expansion to increase annual revenue capacity to approximately $35 million, with a long-term potential of $45 million.

The company maintains a strong balance sheet with $14.8 million in cash and marketable securities and zero outstanding debt.

A stock repurchase program remains active, though management has been highly selective, prioritizing cash for potential M&A opportunities and organic growth.

Operating cash flow increased significantly to $3.2 million, supported by improved inventory management and higher customer deposits on large system orders.

Management is aggressively deploying AI and automation tools across operations to improve scalability, estimating that headcount would only need to grow 30-40% to support a doubling of revenue.

One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.

Backlog has transitioned from being heavily clean energy-focused to being dominated by medical and microelectronics sectors.

The sales pipeline now features larger 'lumpy' orders ranging from $1 million to $5 million, as customers shift from buying individual machines to complex integrated platforms.

Development of the 300-millimeter machine is progressing well, with a formal global debut planned for the Semicon Europe show at the end of the calendar year.

Management noted they feel 'pulled' into this market by customer demand rather than pushing their way in, though actual deliveries will likely fall into fiscal 2028.

The first phase of expansion involves a $500,000 to $600,000 investment in a mezzanine structure to optimize existing vertical space, raising capacity to $35 million.

A second phase involving adjacent leased space could further expand capacity to $45 million to meet the demand for larger production platforms.

Management defended the minimal use of the stock buyback program by emphasizing the need for cash flexibility to pursue 'not cheap' but high-synergy acquisition targets.

The Board of Directors continues to evaluate the timing of buybacks, but currently prioritizes maintaining a 'long runway' for organic and inorganic strategic moves.